CPRX
Catalyst Pharmaceuticals Inc
2 of the 83 super-investors we track hold CPRX, worth a combined $9M per their latest 13F filings. The largest position: Third Avenue Management at 1.1% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 21 of 100 (how strongly the cohort backs it) — ranked #631 of 742 stocks.
Why super-investors own CPRX
CPRX is held by 2 super-investors in our cohort, with a combined position value of $9M. The highest-conviction owner is Third Avenue Management at 1.1% of their portfolio. Cohort ownership has grown from 1 to 2 over the last four quarters — net interest is rising.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2017Q2 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Third Avenue Management | 1.1% | 2q | $7M | 210,161 |
| 2 | Joel Greenblatt | <0.1% | 35q | $3M | 85,147 |
Owners of CPRX also hold
Long US equity 13F-HR filings only. CUSIP 14888U101. Not investment advice.